Oxagen

Developer of drugs for inflammatory and respiratory diseases

placeAbingdon, England, United Kingdom calendar_todayFounded 1997 groups3 employees language oxagen.co.uk

Innovation

46 patent families (8 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 1,550 times.

YearFilings
201211
20139
20145
20151
20164
20181
20212

Investor mix

10 investors on record; lead investors include Bessemer Venture Partners, Red Abbey, Novartis, Omega Funds.

Investor typeCountShare
Venture capital770%
Accelerator & incubator110%
Other / undisclosed220%
Coming soon